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Predicting Periprocedural
Myocardial Infarction
Target-Lesion Plaque
Characterization With Coronary
Computed Tomography Angiography*
Jennifer Malpeso, MD, Matthew J. Budoff, MD
Torrance, California
Periprocedural myocardial infarction (MI) is a well-
recognized complication of percutaneous coronary interven-
tion (PCI) occurring in approximately one-third of elective
cases (1). Mild-to-moderate elevations in cardiac biomark-
ers after PCI have been shown to be associated with
myocardial scar detectable on magnetic resonance imaging
(2,3) and up to a 35% increase in mortality (1); yet whether
post-procedural troponin elevation serves as an independent
predictor of survival is debatable and has not been defini-
tively established (4,5). Regardless, it seems the ability to
identify lesion and vessel characteristics that place patients
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at risk for future procedural-related major adverse cardiac
events would offer interventionalists valuable insight that
might be helpful even in routine revascularization proce-
dures. Prior identification of plaques responsible for these
events would allow prognostic stratification and prompt
initiation of targeted actions to prevent myocardial necrosis,
namely through the use of distal embolic protection devices
(6) and upstream loading with high-dose atorvastatin (7,8).
Furthermore, as more PCI procedures are being done with
same-day discharge, a “high-risk” plaque could be a candi-
date for overnight stay to evaluate for possibility of post-
procedural troponin elevation.
Although many etiologies exist for periprocedural MI
related to PCI, including but not limited to side-branch
occlusion, dissection, and abrupt stent closure, it is distal
embolization of plaque debris or thrombus at the time of
balloon inflation or stent deployment that is generally felt to
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contents of this paper to disclose.be the predominant mechanism. The significant association
between periprocedural MI and adverse long-term clinical
outcomes has led to the development of a variety of invasive
and noninvasive imaging tools all aimed at safely and
accurately identifying salient features of this pathological
substrate predisposed to embolization. Several studies have
examined the relationship between virtual histology-
intravascular ultrasound (VH-IVUS)-derived measures of
plaque volume and composition and rates of distal emboli-
zation (evidenced by ST-segment re-elevation and transient
high-intensity signals on intracoronary Doppler) after PCI
in patients with acute MI, unstable angina, or stable angina
(9–12). Positive correlations were demonstrated between
plaque necrotic core volume and these surrogate markers
(9,10). Plaque necrotic core area emerged as an independent
predictor of periprocedural infarction in patients with stable
angina undergoing elective coronary stenting on the basis of
the direct assessment of levels of cardiac biomarkers 18 to
24 h after the procedure (11,13). More recently, Uetani et
al. (14) reported similar findings with coronary computed
tomography angiography (CCTA)-based plaque quantifica-
tion in 189 consecutive patients undergoing planned coro-
nary intervention. The volume and fraction of low-attenuation
plaque (50 Hounsfield units [HU]) in target lesions was
found to be independently associated with periprocedural
infarction after adjustment for multiple confounders. Interest-
ingly, the fraction of moderate attenuation (50 to 150 HU) or
fibrous plaque inversely correlated with post-procedural levels
of cardiac biomarkers.
As reported by Watabe et al. (15) in this issue of the
Journal, CCTA-based plaque compositional analysis of
culprit lesions in 107 patients with stable angina and normal
cardiac troponin T levels was performed before PCI. Post-
PCI troponin elevation was observed in 36 of 107 patients
(33.6%). Positive remodeling (remodeling index1.05) and
spotty calcification were found to be statistically significant
independent predictors of cardiac troponin T elevation
3 the upper limit of normal (0.010 ng/ml) 24 h after the
procedure, whereas the presence of the 2 plus the finding of
a computed tomography attenuation value 55 HU dem-
onstrated a corresponding positive predictive value of 94%
and a negative predictive value of 90% for said rise.
Transient no-reflow occurred more frequently in patients with
troponin release. Importantly, none of the conventional risk
factors afforded differentiation between patients with and
without post-PCI troponin elevation—observations also noted
in a prior multidetector computed tomography (MDCT) study
(16) and near-infrared spectroscopy data (17). The investiga-
ors conclude that “MDCT might play an important role in
etecting lesions at high risk for myocardial necrosis after
CI.” Of course, the ability to modify this result or intervene
gainst this troponin rise must be prospectively established.
ultidetector computed tomography, although resulting in a
arkedly lower radiation dose than either nuclear imaging or
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contrast use for the patient undergoing the procedure.
Results in the current study echo prior findings (12,14)
and suggest that target-lesion plaque composition might
have a powerful impact on myocardial injury after PCI and
that plaque evaluation on MDCT might play an important
role in planning coronary interventions. It is interesting to
note the high frequency of positive remodeling and spotty
calcification in the plaques prone to embolization in these
stable angina patients, given that these same features are
often associated with so-called vulnerable plaques on
VH-IVUS (18).
Furthermore, the small patient cohort is a notable limi-
tation, as is the lack of concurrent VH-IVUS imaging of
culprit lesions for comparison, at present the only imaging
technique validated to identify patients and lesions at risk
for future major adverse cardiac events. Coronary computed
tomography angiography offers the possibility of identifying
vulnerable atherosclerotic plaques noninvasively. Validation
cohorts and outcome studies would certainly bolster the
enthusiasm for this technique before routine use in this
capacity. Recent rapid advancements in scanner technology
have facilitated the development of manual and automated
methods of plaque quantification and characterization on
computed tomography. These techniques are not without
their own inherent limitations, and future studies compar-
ing CCTA with VH-IVUS and ultimately with histopatho-
logical features are necessary to validate the clinical utility of
this technology.
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